Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.46
SNWV's Cash to Debt is ranked lower than
76% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.56 vs. SNWV: 0.46 )
Ranked among companies with meaningful Cash to Debt only.
SNWV' s 10-Year Cash to Debt Range
Min: 0.03  Med: 186.31 Max: No Debt
Current: 0.46
Equity to Asset -0.77
SNWV's Equity to Asset is ranked lower than
96% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. SNWV: -0.77 )
Ranked among companies with meaningful Equity to Asset only.
SNWV' s 10-Year Equity to Asset Range
Min: -23.67  Med: -1.48 Max: 0.21
Current: -0.77
-23.67
0.21
F-Score: 2
Z-Score: -40.36
M-Score: -1.62
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 1/10

vs
industry
vs
history
Operating margin (%) -556.03
SNWV's Operating margin (%) is ranked lower than
89% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 3.12 vs. SNWV: -556.03 )
Ranked among companies with meaningful Operating margin (%) only.
SNWV' s 10-Year Operating margin (%) Range
Min: -1621.98  Med: -1086.71 Max: -704.01
Current: -556.03
-1621.98
-704.01
Net-margin (%) -501.10
SNWV's Net-margin (%) is ranked lower than
88% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. SNWV: -501.10 )
Ranked among companies with meaningful Net-margin (%) only.
SNWV' s 10-Year Net-margin (%) Range
Min: -2049.73  Med: -930.86 Max: -705.31
Current: -501.1
-2049.73
-705.31
ROA (%) -76.14
SNWV's ROA (%) is ranked lower than
87% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: -0.22 vs. SNWV: -76.14 )
Ranked among companies with meaningful ROA (%) only.
SNWV' s 10-Year ROA (%) Range
Min: -657.17  Med: -214.21 Max: -99.51
Current: -76.14
-657.17
-99.51
ROC (Joel Greenblatt) (%) -56951.22
SNWV's ROC (Joel Greenblatt) (%) is ranked lower than
99% of the 315 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. SNWV: -56951.22 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SNWV' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -52695.24  Med: -23152.94 Max: -4578.32
Current: -56951.22
-52695.24
-4578.32
Revenue Growth (3Y)(%) -20.60
SNWV's Revenue Growth (3Y)(%) is ranked lower than
86% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. SNWV: -20.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
SNWV' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0  Med: -23.45 Max: -12.6
Current: -20.6
EBITDA Growth (3Y)(%) -36.50
SNWV's EBITDA Growth (3Y)(%) is ranked lower than
92% of the 170 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. SNWV: -36.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SNWV' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: -31.85 Max: -24
Current: -36.5
EPS Growth (3Y)(%) -38.70
SNWV's EPS Growth (3Y)(%) is ranked lower than
88% of the 171 Companies
in the Global Medical Devices industry.

( Industry Median: -0.40 vs. SNWV: -38.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SNWV' s 10-Year EPS Growth (3Y)(%) Range
Min: 0  Med: -33.60 Max: -20.4
Current: -38.7
» SNWV's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with SNWV

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
Current Ratio 0.47
SNWV's Current Ratio is ranked lower than
94% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.71 vs. SNWV: 0.47 )
Ranked among companies with meaningful Current Ratio only.
SNWV' s 10-Year Current Ratio Range
Min: 0.04  Med: 0.39 Max: 6.9
Current: 0.47
0.04
6.9
Quick Ratio 0.43
SNWV's Quick Ratio is ranked lower than
94% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.03 vs. SNWV: 0.43 )
Ranked among companies with meaningful Quick Ratio only.
SNWV' s 10-Year Quick Ratio Range
Min: 0.03  Med: 0.34 Max: 6.64
Current: 0.43
0.03
6.64
Days Inventory 364.44
SNWV's Days Inventory is ranked lower than
92% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 131.01 vs. SNWV: 364.44 )
Ranked among companies with meaningful Days Inventory only.
SNWV' s 10-Year Days Inventory Range
Min: 354.14  Med: 571.56 Max: 1032.01
Current: 364.44
354.14
1032.01
Days Sales Outstanding 26.81
SNWV's Days Sales Outstanding is ranked higher than
95% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 68.21 vs. SNWV: 26.81 )
Ranked among companies with meaningful Days Sales Outstanding only.
SNWV' s 10-Year Days Sales Outstanding Range
Min: 18.15  Med: 37.27 Max: 63.88
Current: 26.81
18.15
63.88

Valuation & Return

vs
industry
vs
history
Earnings Yield (Greenblatt) (%) -36.68
SNWV's Earnings Yield (Greenblatt) (%) is ranked lower than
91% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. SNWV: -36.68 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SNWV' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: -72.8  Med: 0.00 Max: 0
Current: -36.68
-72.8
0

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
SANUWAVE Health Inc formerly known as Rub Music Enterprises, Inc., was incorporated in the State of Nevada on May 6, 2004. The Company is a shockwave technology company using a patented system of noninvasive, high-energy, acoustic shockwaves for regenerative medicine and other applications. Its regenerative product in the United States is the demaPACE device, used for treating diabetic foot ulcers subject to submission of satisfactory clinical study results. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The Company faces competition from medical device, biomedical technology and medical products and combination products companies, including major pharmaceutical companies. The Company's product candidates are subject to extensive regulation by the FDA under the Federal Food, Drug, and Cosmetic Act and/or the Public Health Service Act, as well as by other regulatory bodies.
» More Articles for SNWV

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
SANUWAVE Health Encourages Stockholders to Vote on Proposal to Amend Articles of Incorporation Jul 27 2015
SANUWAVE HEALTH, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jul 20 2015
SANUWAVE Health Announces CFO Transition Jul 20 2015
SANUWAVE Health Presents Results Showing Effectiveness of Its Shock Wave Technology for Biofilm... Jul 16 2015
SANUWAVE Health to Showcase its Shock Wave Technology at the 2015 Biofilm Science and Technology... Jul 08 2015
SNWV: Positive Feedback From FDA, Forging Ahead With PMA Jul 01 2015
SANUWAVE HEALTH, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jun 30 2015
SANUWAVE Health Provides an Update on the dermaPACE Clinical Trial Jun 30 2015
SANUWAVE Health to Present at the 2015 Landmark Venture Forum Jun 29 2015
SANUWAVE Health to Hold dermaPACE Clinical Trial Update Conference Call on Tuesday, June 30, 2015 Jun 25 2015
SANUWAVE Receives Its First U.S. Patent for the Energy Industry Regarding the Use of Shock Waves in... Jun 23 2015
SANUWAVE HEALTH, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered... Jun 18 2015
SNWV: Debt Maturity Extended, Provides More Breathing Room Jun 18 2015
SANUWAVE Announces Strengthening of Balance Sheet With Amendment and Extension of Promissory Notes Jun 18 2015
SANUWAVE HEALTH, INC. Financials May 20 2015
SANUWAVE Health to Present at Upcoming Financial Conferences May 14 2015
10-Q for SANUWAVE Health, Inc. May 08 2015
SANUWAVE HEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation... May 07 2015
SANUWAVE HEALTH, INC. Files SEC form 10-Q, Quarterly Report May 06 2015
SANUWAVE Health Reports First Quarter Financial Results and Provides a Business Update May 06 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK